Filip Y F L De Vos Selected Research

Filip Y F L De Vos Research Topics

3	Neoplasms (Cancer) 04/2021 - 10/2013
2	Nausea 01/2022 - 01/2019
2	Edema (Dropsy) 01/2022 - 01/2019
2	Fatigue 01/2022 - 01/2019
2	Diarrhea 01/2022 - 01/2019
1	Exanthema (Rash) 01/2022
1	Anemia 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Vision Disorders (Hemeralopia) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Vomiting 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Proteinuria 01/2019
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Venous Thromboembolism 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2013
1	Seminoma 10/2013
1	Neoplasm Metastasis (Metastasis) 10/2013
1	Liver Diseases (Liver Disease) 10/2013
1	Eosinophilia 10/2013
1	Pneumonia (Pneumonitis) 10/2013

2	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019 - 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	binimetinibIBA 01/2022
1	ribociclibIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	depatuxizumab mafodotinIBA 01/2021
1	Lomustine (CCNU)FDA Link 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2018
1	olaparibIBA 11/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2013